Back to Authors

Yang, Yul W.

https://orcid.org/0000-0001-5465-0357

Mayo Clinic

Mayo Clinic

Citations 16

Patient Use of Physicians’ First (Given) Name in Direct Patient Electronic Messaging
Harvey, Jamison A. , Butterfield, Richard , Ochoa, Shari A. , Yang, Yul W.

JAMA Network Open | October 5, 2022 | Volume: 5 | Issue: 10 | Pages: e2234880

10.1001/jamanetworkopen.2022.34880 Get It

This cohort study examines factors that may contribute to whether patients address physicians differently through electronic messaging
Reevaluating Corticosteroid Classification Models in Patient Patch Testing
Chen, Joyce Y., Yiannias, James A. , Hall, Matthew R., Youssef, Molly J. , Drage, Lisa A., Davis, Mark D.P. , Yang, Yul W.

JAMA Dermatology | September 28, 2022 | Volume: 158 | Issue: 11 | Pages: 1279

10.1001/jamadermatol.2022.3774 Get It

Importance Individuals with allergic contact dermatitis to one topical corticosteroid may also react to other corticosteroids. Corticosteroid classification models have been proposed to predict such copositivity, recommend representative screening corticosteroids, and guide allergen avoidance. Objective To use patient data to determine copositivity patterns between corticosteroids and evaluate against previous corticosteroid classification models. Design, Setting, and Participants This qualitative study included a retrospective analysis of the Mayo Clinic Contact Dermatitis Group corticosteroid patch test data from 2010 to 2019. Among patients undergoing patch testing with the Mayo Clinic’s standard or steroid series who consented to research participation, 5637 patients were included in the analysis. Copositivity rates were determined between corticosteroids and analyzed by hierarchical clustering for comparison to previous classification models. Main Outcomes and Measures The frequency of patch test positivity to each of the analyzed corticosteroids was noted and compared with previously published patch test positivity rates. Copositivity rates between each pair of corticosteroids were determined, and overall copositivity patterns were analyzed and evaluated against known steroid classes. Results A total of 49 472 individual patches were applied to 5637 patients, testing 18 corticosteroids. Patch test positivity rates ranged between 0.3% and 4.7%. The fluocinonide positivity rate corresponded to the highest copositivity rate with other corticosteroids (mean [SD], 50.7% [26.1%]). Tixocortol-21-pivalate, 0.1%, and tixocortol-21-pivalate, 1%, positivity rates corresponded to the lowest copositivity rates (mean [SD], 4.1% [1.7%] and 3.6% [1.4%], respectively). Hierarchical clustering elucidated patterns that did not support previous corticosteroid classification models. Conclusions and Relevance In this qualitative study, copositivity rates were variable between corticosteroids, and overall patch test positivity for allergy to topical corticosteroids was rare. Previously published corticosteroid classifications are not supported by real patient-derived data and may not be accurate in predicting corticosteroid copositivity.
Treatment of granuloma annulare and related granulomatous diseases with sulphasalazine: a series of 16 cases
Yang, Yul W. , Lehrer, Michael, Mangold, Aaron R. , Yiannias, James A. , Nelson, Steven A. , Pittelkow, Mark R. , Yang, Y W , Mangold, A R , Lehrer, M.D.

Journal of the European Academy of Dermatology and Venereology | March 26, 2020 | Volume: 35 | Issue: 1 | Pages: 211-215

10.1111/jdv.16356 Get It

AbstractBackgroundGranuloma annulare (GA) and the related annular elastolytic giant cell granuloma (AEGCG) and interstitial granulomatous dermatitis (IGD) are idiopathic histiocytic inflammatory disorders, which are frequently recalcitrant to treatment.ObjectivesEvaluate the efficacy of sulphasalazine in treating GA, AEGCG and IGD.MethodsSixteen patients were identified with granulomatous disease who were treated with sulphasalazine between September 2015 and September 2019. Outcomes were based on patients’ and providers’ subjective evaluations.ResultsSixteen patients were included in the study (ages 56–89, four male and twelve female). Previous treatments were attempted in fifteen patients. Clinical improvement was seen in fourteen patients (87.5%). Initial improvement was noted within a mean (SD) of 66.4 (35.1) days after starting therapy, with increasing benefits over time. Ten patients (62.5%) reported complete or near‐complete clearance, three patients (18.8%) reported significant improvement, and one (6.3%) reported partial improvement. Twelve patients elected to stop or reduce therapy, resulting in relapse or worsening in five patients.ConclusionsSulphasalazine may be considered as treatment for GA and GA‐related conditions.
Gray-Brown Patches on the Face of a 62-Year-Old Woman
Yang, Yul W. , Nelson, Steven A. , Ochoa, Shari A.

JAMA Dermatology | February 14, 2018 | Volume: 154 | Issue: 6 | Pages: 717

10.1001/jamadermatol.2017.5831 Get It

Dermoscopic Findings of Irritant “Poral” Reactions to Cobalt During Patch Testing
Yang, Yul W. , Costello, Collin M. , Mangold, Aaron R. , Mangold, A R , Costello, Collin M

Dermatitis® | October 22, 2017 | Volume: 28 | Issue: 6 | Pages: 367-367

10.1097/der.0000000000000322 Get It

Polarized transilluminating dermoscopy: Bedside trichoscopic diagnosis of trichothiodystrophy
Yang, Yul W. , Yarbrough, Kevin B., Mitkov, Mario , Russi, Daniela, Price, Harper , Swanson, David C. , Swanson, David L, Price, Harper N

Pediatric Dermatology | September 25, 2017 | Volume: 35 | Issue: 1 | Pages: 147-149

10.1111/pde.13290 Get It

AbstractTrichothiodystrophy is a rare autosomal recessive disorder resulting in a broad range of systemic abnormalities. Polarizing microscopy of the hair reveals the pathognomic “tiger tail” of alternating light and dark bands, but the need for a microscope prevents rapid bedside diagnosis. We describe a new technique for the bedside diagnosis of trichothiodystrophy using a handheld polarizing dermatoscope, precluding the need for microscopic examination.